Q2 2015 Holdings
Filed 2015-08-13 | 91 holdings | $366.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COMMON | 09062X103 | $196.9M | 487,432 | 53.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COMMON | 09061G101 | $132.1M | 965,877 | 36.1% |
| Align Tech Inc(ALGN) | COMMON | 016255101 | $29.7M | 473,522 | 8.1% |
| Ascendis Pharma A S(ASND) | SP ADR | 04351P101 | $4.2M | 235,560 | 1.1% |
| Amphastar Pharmaceuticals(AMPH) | SHARES | 03209R103 | $640.0K | 36,400 | 0.2% |
| Coherus Biosciences(CHRS) | COMMON | 19249H103 | $462.0K | 15,974 | 0.1% |
| Gilead Sciences Inc(GILD) | COMMON | 375558103 | $152.7K | 1,304,407 | 0.0% |
| Celgene Corp(CELG) | COMMON | 151020104 | $145.5K | 1,257,558 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COMMON | 015351109 | $118.9K | 657,525 | 0.0% |
| Incyte Corporation(INCY) | COMMON | 45337C102 | $94.8K | 910,114 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COMMON | 75886F107 | $89.2K | 174,900 | 0.0% |
| Amgen Inc(AMGN) | COMMON | 031162100 | $87.0K | 566,497 | 0.0% |
| Halozyme Therapeutic(HALO) | COMMON | 40637H109 | $78.5K | 3,477,051 | 0.0% |
| Thermo Fisher Scientific(TMO) | COMMON | 883556102 | $76.6K | 590,036 | 0.0% |
| Vertex Pharmaceuticals(VRTX) | COMMON | 92532F100 | $73.9K | 598,800 | 0.0% |
| Amicus Therapeutics(FOLD) | COMMON | 03152W109 | $70.8K | 5,004,322 | 0.0% |
| Pfizer Inc(PFE) | COMMON | 717081103 | $61.3K | 1,828,538 | 0.0% |
| Seattle Genetics Inc | COMMON | 812578102 | $61.1K | 1,262,075 | 0.0% |
| Portola Pharmaceuticals | COMMON | 737010108 | $53.3K | 1,169,130 | 0.0% |
| Allergan PLC | SHARES | G0177J108 | $48.9K | 161,031 | 0.0% |
| Intercept Pharmaceuticals(ICPTUSD) | COMMON | 45845P108 | $42.9K | 177,647 | 0.0% |
| Tetraphase Pharmaceuticals | COMMON | 88165N105 | $42.4K | 893,076 | 0.0% |
| Medtronic PLC(MDT) | SHARES | G5960L103 | $38.5K | 519,829 | 0.0% |
| Alder Biopharmaceuticals(ALDR1EUR) | COMMON | 014339105 | $36.2K | 682,736 | 0.0% |
| Merck & Co Inc(MRK) | COMMON | 58933Y105 | $34.9K | 613,842 | 0.0% |
| Boston Scientific(BSX) | COMMON | 101137107 | $33.0K | 1,870 | 0.0% |
| Dexcom Inc(DXCM) | COMMON | 252131107 | $31.8K | 398,158 | 0.0% |
| Oncomed Pharmaceuticals | COMMON | 68234X102 | $30.8K | 1,369,534 | 0.0% |
| United Therapeutics(UTHR) | COMMON | 91307C102 | $30.6K | 175,780 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COMMON | 69366J200 | $29.6K | 614,742 | 0.0% |
| Relypsa Inc | COMMON | 759531106 | $27.9K | 842,030 | 0.0% |
| Shire PLC | SP ADR | 82481R106 | $27.5K | 113,812 | 0.0% |
| Abbott Labs(ABT) | COMMON | 002824100 | $26.6K | 541,734 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $25.6K | 376,951 | 0.0% |
| ZS Pharma Inc | COMMON | 98979G105 | $24.4K | 465,839 | 0.0% |
| Edwards Lifescience(EW) | COMMON | 28176E108 | $22.2K | 155,825 | 0.0% |
| Chimerix Inc(CMRXEUR) | COMMON | 16934W106 | $21.9K | 474,900 | 0.0% |
| Clovis Oncology(CLVSEUR) | COMMON | 189464100 | $21.7K | 246,952 | 0.0% |
| Teva Pharmaceutical(TEVA) | ADR | 881624209 | $21.3K | 359,832 | 0.0% |
| Acceleron Pharma(XLRN) | COMMON | 00434H108 | $20.6K | 652,084 | 0.0% |
| Karyopharm Therapeutics(KPTIEUR) | COMMON | 48576U106 | $19.4K | 712,968 | 0.0% |
| Uniqure N.V.(QURE) | SHARES | N90064101 | $17.5K | 649,800 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COMMON | 46120E602 | $17.5K | 36,188 | 0.0% |
| Nxstage Medical | COMMON | 67072V103 | $16.7K | 1,172,196 | 0.0% |
| Immune Design Corp | COMMON | 45252L103 | $16.7K | 810,390 | 0.0% |
| Novartis AG(NVSN) | SP ADR | 66987V109 | $16.6K | 168,505 | 0.0% |
| Accuray Inc(ARAY) | COMMON | 004397105 | $16.0K | 2,395 | 0.0% |
| HCA Hldgs Inc(HCA) | COMMON | 40412C101 | $16.0K | 175,945 | 0.0% |
| Invitae Corp(NVTA1EUR) | COMMON | 46185L103 | $13.8K | 929,765 | 0.0% |
| DR Reddys Labs LTD(RDY) | ADR | 256135203 | $13.7K | 247,714 | 0.0% |